Fmoc-Ala-OH-13C3
Modify Date: 2024-01-09 17:57:37
Fmoc-Ala-OH-13C3 structure
|
Common Name | Fmoc-Ala-OH-13C3 | ||
|---|---|---|---|---|
| CAS Number | 765259-05-0 | Molecular Weight | 314.31 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C1513C3H17NO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Fmoc-Ala-OH-13C3Fmoc-Ala-OH-13C3 is a 13C-labeled Fmoc-leucine. Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-ind |
| Name | Fmoc-Ala-OH-13C3 |
|---|
| Description | Fmoc-Ala-OH-13C3 is a 13C-labeled Fmoc-leucine. Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-ind |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[75]. |
| References |
| Molecular Formula | C1513C3H17NO4 |
|---|---|
| Molecular Weight | 314.31 |